Ibrutinib resistance is mostly due to specific mutation of BTK or phospholipase gamma downstream of BTK, and these mutations frequently lead to a Richter transformation from chronic lymphocytic leukemia to diffuse large B cell lymphoma. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.